250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 5 Wine And Spirits VC (Venture Capital) Funds in Germany in November 2024

A list of 5 VC (Venture Capital) funds that invest in Wine and spirits startups based in Germany. We rank investors based on the number of investments they made in Wine and spirits companies from Germany. We update this investor list every month.

Top 5 Wine And Spirits VC (Venture Capital) Funds in Germany in November 2024

Investor Wine And Spirits Germany investments
Loyal VC 2
CNB Capital 1
SquareOne 1
Brandenburg Kapital 1
Ace Ventures 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Loyal VC VC Fund · Toronto, Ontario, Canada · 3 investments in the past 12 months
Loyal runs a global venture fund with quarterly redemptions and a proprietary gate-stage process, reducing investment bias and unlocking greater returns. Partnered with INSEAD, Founder Institute, and 500+ advisors, we are Loyal to the world with 250+ investments in 50+ countries.
Show more
Investment focus
  • Artificial Intelligence, Software, E-Commerce
  • Pre-Seed, Seed, Funding Round
  • United States, Canada, United Kingdom
Portfolio highlights
  • UTOBO INC. — utobo is the one-stop platform for educators and coaching services to take live classes, create courses and test series, and sell them online in just 30 minutes.
  • NIU NIU — NIU NIU is an e-Waste operating system that maximizes critical mineral extraction, while minimizing the environmental and social impact
  • The Leaf Protein Company — Unlocking Earth's most abundant source of proteins - green leaves.
CNB Capital VC Fund · Vienna, Wien, Austria · 3 investments in the past 12 months
CNB Capital believes in the power of technology-driven entrepreneurship. We understand real innovation creates moat and defensibility. We provide long-term commitment, building an enduring partnership without the usual exit pressure.
Show more
Investment focus
  • Software, Machine Learning, Information Technology
  • Series A, Funding Round, Seed
  • Germany, Austria, Switzerland
Portfolio highlights
  • Hydrogrid — All-in-one solution for optimizing hydropower plants. Increase revenues by up to 18%, reduce spill by up to 12%, and save valuable time with Hydrogrid Insight.
  • watttron — Watttron invents a revolutionary heating system that can heat up surfaces heterogeneously.Watttron develops an innovative heating technology that can be used in various industrial processes. It is superior to current heating systems in many ways and offers a number of advantages. On the following pages, you will find information about possibleapplications and opportunities.The company is located in the Technologie- und Gründerzentrum Freital – a technology and start-up center on the outskirts of Dresden, the state capital of Saxony.
  • Neural Concept — Neural Concept is the first AI software for enhanced engineering. Leverage your historical CAD and CAE data to drastically shorten and improve your design cycles.
SquareOne VC Fund · Berlin, Berlin, Germany
We invest in B2B tech entrepreneurs who are obsessed with solving complex problems in huge markets at pre-seed and seed stage
Show more
Investment focus
  • Software, SaaS, E-Commerce
  • Seed, Series A, Funding Round
  • Germany, United States, Poland
Portfolio highlights
  • Hero — Hero is a B2B payments and financing platform, offer direct online payment experience and receive your money immediately.
  • Otterspace — Otterspace takes care of DAOs.
  • Flinn — We are driven to impact the health of millions of people around the globe by enabling medical companies to launch and operate products more efficiently. To make this vision come true, we established a customer-centric, experimentation-driven product development approach.
Brandenburg Kapital VC Fund · Potsdam, Brandenburg, Germany · 6 investments in the past 12 months
With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB).
Show more
Investment focus
  • Information Technology, Software, Health Care
  • Seed, Series A, Funding Round
  • Germany, United Kingdom
Portfolio highlights
  • Mateo — Mateo is the omni-channel customer experience powerhouse that empowers local brands and businesses to drive growth through a digital customer lifecycle management. From acquiring new leads, converting them into customers and extending those relationships - all in one platform.
  • family.cards — Family.cards provides elders with barrier-free access to digital solutions and all the tools they need to manage their circumstances.
  • Sphingotec GmbH — Improving patient outcomes with innovative diagnostics for critical care: Actionable insights in real-time
Ace Ventures VC Fund · Potsdam, Brandenburg, Germany
Ace Ventures was designed to help new ideas, smart people and great companies to successfully enter the Internet business in Germany.
Show more
Investment focus
  • Apps, Electronics, Wine And Spirits
  • Series B, Seed, Series A
  • Germany, United States, Italy
Portfolio highlights
  • iMediSync — iMediSync provides automatic brain wave analysis and neuromodulation solutions.
  • Joy — Experience wedding planning the way it should be, from beautiful wedding websites and invitations, to registries and online RSVP.
  • Kither Biotech — Kither Biotech is a pharmaceutical product company that focuses its R&D activities on the development of new drugs. The R&D activities of the company mainly involve the development of new drugs to treat chronic inflammatory diseases.In recent years Kither has focused its first line of activities on the development of a small peptide(KIT2014) developed internally for the treatment of cystic fibrosis, a disease that predominantly affects the lungs and that currently has no cure. The KIT2014 peptide was assigned the Orphan Drug designation from the European Medicines Agency. The KIT2014 compound is currently undergoing the pre-clinical phase of clinical development.Kither’s product portfolio also includes a molecule (CL27), also developed internally, that is being developed for the treatment of Chronic Obstructive Pulmonary Diseases and Allergic Asthma. The company is about to start the pre-clinical phase of development of the CL27 molecule.
Investors by industry
Investors by country
VC (Venture Capital) Funds in Germany by industry